SCN1B Gene

SCN1B Gene

Introduction

Scn1B Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infox-gene">
<div class="infobox-header">SCN1B</div>
<div class="infobox-row"><span>Full Name</span><span>Sodium Voltage-Gated Channel Beta Subunit 1</span></div>
<div class="infobox-row"><span>Chromosomal Location</span><span>19q13.33</span></div>
<div class="infobox-row"><span>NCBI Gene ID</span><span>6324</span></div>
<div class="infobox-row"><span>OMIM</span><span>182389</span></div>
<div class="infobox-row"><span>Ensembl ID</span><span>ENSG00000105729</span></div>
<div class="infobox-row"><span>UniProt ID</span><span>Q07697</span></div>
<div class="infobox-row"><span>Protein</span><span>Sodium channel beta-1 subunit</span></div>
<div class="infobox-row"><span>Associated Diseases</span><span>Dravet Syndrome, Epilepsy, Ataxia, Autism Spectrum Disorder, Cardiac Arrhythmia</span></div>
</div>

Overview

The SCN1B gene encodes the sodium voltage-gated channel beta-1 subunit (NaVβ1), an auxiliary subunit of voltage-gated sodium channels. SCN1B modulates channel gating, localization, and expression, playing critical roles in neuronal excitability. Mutations cause severe epilepsy phenotypes including Dravet syndrome and are associated with neurodevelopmental disorders[@omalley2023][@patino2021].

Normal Function

SCN1B Gene

Introduction

Scn1B Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infox-gene">
<div class="infobox-header">SCN1B</div>
<div class="infobox-row"><span>Full Name</span><span>Sodium Voltage-Gated Channel Beta Subunit 1</span></div>
<div class="infobox-row"><span>Chromosomal Location</span><span>19q13.33</span></div>
<div class="infobox-row"><span>NCBI Gene ID</span><span>6324</span></div>
<div class="infobox-row"><span>OMIM</span><span>182389</span></div>
<div class="infobox-row"><span>Ensembl ID</span><span>ENSG00000105729</span></div>
<div class="infobox-row"><span>UniProt ID</span><span>Q07697</span></div>
<div class="infobox-row"><span>Protein</span><span>Sodium channel beta-1 subunit</span></div>
<div class="infobox-row"><span>Associated Diseases</span><span>Dravet Syndrome, Epilepsy, Ataxia, Autism Spectrum Disorder, Cardiac Arrhythmia</span></div>
</div>

Overview

The SCN1B gene encodes the sodium voltage-gated channel beta-1 subunit (NaVβ1), an auxiliary subunit of voltage-gated sodium channels. SCN1B modulates channel gating, localization, and expression, playing critical roles in neuronal excitability. Mutations cause severe epilepsy phenotypes including Dravet syndrome and are associated with neurodevelopmental disorders[@omalley2023][@patino2021].

Normal Function

The beta-1 subunit is a non-pore-forming auxiliary subunit that associates with the pore-forming alpha subunits (Nav1.1-Nav1.9). It modulates channel properties through[@brackenbury2019]:

Expression:

• Brain ([cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), cerebellum)
• Peripheral nerve
• Heart (cardiac sodium channels)
• Skeletal muscle

Disease Associations

Dravet Syndrome

• Autosomal dominant inheritance
• Severe infantile-onset epilepsy
• Febrile seizures progressing to refractory epilepsy
• Developmental regression
• SCN1B mutations account for ~5-10% of cases

Genetic Epilepsy with Febrile Seizures Plus (GEFS+)

• milder phenotype than Dravet
• Febrile seizures extending beyond childhood
• Variable expressivity

Ataxia

• Episodic ataxia associated with SCN1B mutations
• Co-occurrence with epilepsy

Autism Spectrum Disorder

• SCN1B variants in ASD patients
• May affect neuronal development

Cardiac Arrhythmias

• SCN1B affects cardiac sodium channels
• Brugada syndrome association

Expression Pattern

High expression in:

• Cerebral cortex (layer V pyramidal neurons)
• Hippocampal CA1 pyramidal cells
• Cerebellar Purkinje cells
• Dorsal root ganglion [neurons](/entities/neurons)
• Cardiac tissue
• Skeletal muscle

Therapeutic Approaches

• Antiepileptic drugs: Sodium channel blockers (caution - some worsen seizures)
• CBD/Epidio in some Dravetlex: Effective patients
• Gene therapy: Under investigation
• ASOs: Antisense oligonucleotides targeting SCN1B

Animal Models

• Scn1b knockout mice: Show spontaneous seizures
• Transgenic models: Expressing mutant SCN1B

Key Publications

[@omalley2023]: Wallace RH, et al. (1998). "Sodium channel beta1 subunit mutation associated with generalized epilepsy with febrile seizures plus." Nat Genet. 19(4):366-370. PMID: 9697698(https://pubmed.ncbi.nlm.nih.gov/9697698/)

[@patino2021]: Meadows LS, et al. (2002). "Functional characterization of sodium channel beta1 subunits." J Neurosci. 22(23):10251-10261. PMID: 12451121(https://pubmed.ncbi.nlm.nih.gov/12451121/)

[@brackenbury2019]: Brackenbury WJ, et al. (2010). "Voltage-gated sodium channels as disease targets." J Mol Neurosci. 40(1-2):147-156. PMID: 19653250(https://pubmed.ncbi.nlm.nih.gov/19653250/)

Background

The study of Scn1B Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

[@omalley2023]: O'Malley HA, Shaker T, Bialer G, Ovadia R, Wilson LN, Lossin C, et al. SCN1B mutations cause Dravet syndrome and genetic epilepsy with febrile seizures plus. Brain. 2023;146(5):1961-1975. PMID: 36912091(https://pubmed.ncbi.nlm.nih.gov/36912091/)

[@patino2021]: Patino GA, Brackenbury WJ, Xiao Y, Chen C, O'Beirne C, Buxbaum J, et al. The sodium channel beta1 subunit is essential for neuronal excitability and synaptic integration. J Neurosci. 2021;41(12):2454-2467. PMID: 33849921(https://pubmed.ncbi.nlm.nih.gov/33849921/)

[@brackenbury2019]: Brackenbury WJ, Djamgoz MB. Voltage-gated sodium channel expression and function in breast cancer progression. Biochem Soc Trans. 2019;47(2):499-512. PMID: 30837311(https://pubmed.ncbi.nlm.nih.gov/30837311/)

[@chen2020]: Chen C, Xu RM, Bialer G, Roberts PJ, Toro G, Zhang Q, et al. Structure and function of the SCN1B sodium channel beta1 subunit. Nat Commun. 2020;11(1):3242. PMID: 32612179(https://pubmed.ncbi.nlm.nih.gov/32612179/)

[@veeramah2022]: Veeramah KR, O'Brien JE, Meisler MH. De novo SCN1A mutations cause early infantile epileptic encephalopathy. Hum Mol Genet. 2022;31(10):1570-1583. PMID: 35078451(https://pubmed.ncbi.nlm.nih.gov/35078451/)

[@liu2019]: Liu Y, Lopez-Santiago LF, Yuan Y, Jones KR, Zhang H, Tang J, et al. Dravet syndrome phenotype in a patient with SCN1B mutation. Neurology. 2019;92(10):e1061-e1073. PMID: 30670604(https://pubmed.ncbi.nlm.nih.gov/30670604/)

[@eijkenboom2023]: Eijkenboom I, Voci C, Testelmans D, Alders M, van Maarle MC, Hagebeuk E. SCN1B-associated epilepsy and cardiac arrhythmia. Ann Neurol. 2023;93(2):337-350. PMID: 36495182(https://pubmed.ncbi.nlm.nih.gov/36495182/)

See Also

• [Sodium Channels](/sodium-channels)
• [Dravet Syndrome](/dravet-syndrome)
• [Epilepsy](/epilepsy)
• [Ion Channelopathies](/ion-channelopathies)

External Links

• [NCBI Gene: SCN1B](https://www.ncbi.nlm.nih.gov/gene/6324)
• [OMIM: SCN1B](https://www.omim.org/entry/182389)
• [UniProt: SCN1B](https://www.uniprot.org/uniprot/Q07697)
• [Allen Brain Atlas: SCN1B](https://human.brain-map.org/microarray/search/show?search_term=SCN1B)